Biosphere

Biosphere

Provides industrial bioreactors for sustainable bioproducts

Overview

Biosphere develops and integrates bioreactor technology to power industrial biomanufacturing for sustainable production of global commodities like food, fuel, and materials. It deploys bioreactor systems inside large-scale facilities, providing hardware, integration, and ongoing services to tailor and optimize bioproduct production. The company differentiates itself by pairing advanced bioreactors with platform-scale integration and offering licensing and deployment options for industrial adoption in the global commodities market. Its goal is to make large-scale bioproduct production financially viable and environmentally sustainable, accelerating the shift from monocropping, factory farming, and petroleum refining to bio-based production worldwide.

About Biosphere

Simplify's Rating
Why Biosphere is rated
C+
Rated B on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Industrial & Manufacturing

Energy

Biotechnology

Company Size

11-50

Company Stage

Seed

Total Funding

$8.8M

Headquarters

Oakland, California

Founded

2022

People at Biosphere

People at Biosphere who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The $9M U.S. Army contract for portable bioreactors producing 2,800-calorie meals validates scalable on-demand nutrition for warfighters.
  • Gas fermentation enables low-cost protein production from CO₂ and hydrogen, reducing input costs and contamination risks.
  • UV sterilization reduces maintenance costs and allows cheaper materials like HDPE, unlocking favorable unit economics across food and fuel.

What critics are saying

  • Rising hydrogen prices or supply constraints will directly increase production costs and stall protein-from-air scaling within 9–12 months.
  • Scaling gas-liquid mass transfer to 20,000L has failed for 3+ competitors, risking prototype delivery delays within 12–18 months.
  • HDPE degradation under UV exposure and contamination risks in large reactors threaten batch failures amid warfighter ration demands within 6–12 months.

What makes Biosphere unique

  • Biosphere replaces 1950s steam sterilization with proprietary UV sterilization, slashing capital intensity by up to 10x.
  • Its UV-enabled design enables modular, rapidly deployable bioreactors for on-site protein synthesis in austere environments.
  • The acquisition of NovoNutrients in June 2026 strengthens gas fermentation capabilities with validated loop reactor technology.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$8.8M

Above

Industry Average

Funded Over

1 Rounds

Notable Investors:
Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$8.8M
Biosphere

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Sick Leave

Paid Holidays

Parental Leave

Company Equity

Gym Membership

Growth & Insights

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%

Recently Posted Jobs

Sign up to get curated job recommendations

Biosphere is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →